Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The Diabetes Therapeutics Market Today And What Is Its Future Size?

The market size for diabetes therapeutics has seen a swift expansion in the recent past. It is predicted to increase from $153.67 billion in 2024 to $170.06 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.7%. The escalation during the historically significant period is attributable to the initial rise in diabetes instances, increased utilization of oral hypoglycemic drugs, early adoption of injectable insulin treatments, instruction on self-care, and the arrival of biosimilar insulins on the market.

It is anticipated that the diabetes therapeutics market will experience rapid expansion in the coming years, rising to a worth of $252.95 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 10.4%. The expected growth can be linked to a rise in digital literacy, increased use of injectable non-insulin medication, the development of digital health platforms, a heightened demand for personalized and combination treatments, as well as enhanced healthcare infrastructure and access to treatment for diabetes. Key trends observed during the forecast period comprise automated insulin delivery (aid) systems, the use of artificial intelligence (ai) in diabetes management, device interoperability, digital healthcare applications, and the use of remote patient monitoring (rpm).

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25749&type=smp

What External And Internal Drivers Are Influencing The Diabetes Therapeutics Market?

The escalating occurrence of obesity is projected to stimulate the expansion of the diabetes therapeutics market in the future. Obesity describes an undue accrual of fat that poses a health hazard and is a significant risk component for type 2 diabetes. The surge in obesity rates can be attributed to the mounting intake of calorie-dense diets, with an increased number of individuals consuming processed and junk foods loaded with sugar and fat, coupled with diminished physical exertion, resulting in excessive weight accumulation. Diabetes therapeutics play a crucial role in the management of obesity by enhancing blood glucose regulation and promoting weight reduction through drugs such as GLP-1 receptor agonists, which curtail appetite and decelerate digestion, thereby ameliorating the comprehensive metabolic health of obese individuals. For instance, as indicated by a report issued by the Office for Health Improvement and Disparities in the UK in May 2024, approximately 64% of adults aged 18 and above were categorized as overweight or living with obesity in 2022 to 2023, showing an escalation from the prior year’s statistic of 63.8%. Hence, the escalating prevalence of obesity is a key driver for the expansion of the diabetes therapeutics market.

How Is The Diabetes Therapeutics Market Categorized Across Applications And Types?

The diabetes therapeutics market covered in this report is segmented –

1) By Drug: Oral Anti-Diabetic Drugs, Insulin, Non-Insulin Injectable Drug, Combination Drug

2) By Type: Diabetes 1, Diabetes 2

3) By Route Of Administration: Oral, Subcutaneous, Intravenous

4) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies

5) By Application: Preventive, Treatment Or Care

Subsegments:

1) By Oral Anti-Diabetic Drugs: Biguanides, Sulfonylureas, DPP-4 Inhibitors, SGLT-2 Inhibitors, Thiazolidinediones, Meglitinides, Alpha-Glucosidase Inhibitors

2) By Insulin: Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Premixed Insulin

3) By Non-Insulin Injectable Drug: GLP-1 Receptor Agonists, Amylin Analogs

4) By Combination Drug: Oral Combination Therapies, Oral and Injectable Combination Therapies

How Are Market Trends Influencing Competition In The Diabetes Therapeutics Market?

Leading corporations active in the realm of diabetes therapeutics are directing their efforts towards the creation of innovative solutions like cognitive behavioral therapy (CBT). Their intent is to amplify personalized management of diabetes and foster better glycemic control in type 2 diabetes patients. CBT is essentially a systematic, evidence-backed psychological intervention which aids individuals in identifying and transforming detrimental thought processes and behaviours. For example, in October 2023, Better Therapeutics Inc., a digital therapeutics firm from the US, unveiled AspyreRx, an innovative digital therapeutic app specifically designed for diabetes. FDA authorized, AspyreRx offers customized cognitive behavioral therapy (CBT) for patients 18 years or older in order to bolster behavioral alterations which amplify diabetes management. Initially labeled as BT-001, AspyreRx has proven to induce significant and enduring reductions in A1c when compared to conventional care. These results were consistent with a decided enhancement in factors such as blood pressure, body weight, emotional health and overall quality of life, as reflected in a randomized controlled trial.

Who Are The Global Leaders Steering The Diabetes Therapeutics Market Forward?

Major companies operating in the diabetes therapeutics market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Medtronic plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Biocon Biologics Limited, MannKind Corporation, Tandem Diabetes Care Inc., Lexicon Pharmaceuticals Inc., Better Therapeutics Inc., Adocia S.A., Oramed Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/diabetes-therapeutics-global-market-report

What Are The Emerging Regional Trends Driving The Diabetes Therapeutics Market?

North America was the largest region in the diabetes therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=25749&type=smp

Browse Through More Reports Similar to the Global Diabetes Therapeutics Market 2025, By The Business Research Company

Clinical Nutrition For Diabetes Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-diabetes-care-global-market-report

Antidiabetics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

Diabetes Care Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

About The Business Research Company:

With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model